Literature DB >> 23264096

All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).

J H Kim1, G Psevdos, E Gonzalez, S Singh, M C Kilayko, V Sharp.   

Abstract

PURPOSE: The overall mortality rate among human immunodeficiency virus (HIV)-infected patients has significantly declined in the era of highly active antiretroviral therapy (HAART). However, little is known about the causes of death for HIV-infected patients who are hospitalized in acute care hospitals.
METHODS: A retrospective chart review of hospitalized HIV-infected patients from 2004 to 2008 was undertaken.
RESULTS: Among 9,101 hospitalized HIV-infected patients, 237 deaths were identified, with an overall mortality rate of 237/9,101 (2.6 %). The mortality rate did not differ from year to year (2-3 %). Charts for 208 patients were available for review and were analyzed. The following medians were noted: age 49 years, CD4+ T cell count 137 cells/μL, HIV viral load (VL) log10 3.93, length of stay 16 days. The proportion of men were 71.6 %, African Americans (AAs) were 62.5 %, and HAART use was 52.4 %, with an overall good adherence rate of only 17.3 %. The major causes of death were non-acquired immunodeficiency syndrome (AIDS)-related illness (81.7 %, 170/208): sepsis (34.6 %, 72/208), non-recurrent bacterial pneumonia (19.7 %, 41/208), cardiac disease (5.8 %, 12/208), liver disease (4.3 %, 9/208), and non-AIDS-related malignancy (4.3 %, 9/208). The major causes of death due to AIDS-related illness (18.3 %, 38/208) were: Pneumocystis jirovecii pneumonia (4.8 %, 10/208) and AIDS-related encephalopathy, including progressive multifocal leukoencephalopathy/cryptococcal meningitis/cerebral toxoplasmosis (3.4 %, 7/208). Mortality due to AIDS-related illnesses was associated with younger age (median age 44 vs. 50 years, p = 0.001), female sex (44.7 vs. 24.7 %, p = 0.013), and lower CD4+ T cell counts (median 10 vs. 66, p = 0.001).
CONCLUSION: The mortality rate in our hospitalized HIV-infected patients remained low. Non-AIDS-related illnesses were the major causes of death, with sepsis being the most common. Low CD4+ T cell count and female sex were associated with deaths due to AIDS-related illness. Poor adherence to HAART was also noted in those patients to whom treatment was offered in the outpatient setting. Further prospective studies are needed in order to better define the epidemiology and outcomes for hospitalized HIV-infected patients in the era of HAART.

Entities:  

Mesh:

Year:  2012        PMID: 23264096     DOI: 10.1007/s15010-012-0386-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

1.  Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.

Authors:  Colette Smith; Caroline A Sabin; Jens D Lundgren; Rodolphe Thiebaut; Rainer Weber; Matthew Law; Antonella d'Arminio Monforte; Ole Kirk; Nina Friis-Moller; Andrew Phillips; Peter Reiss; Wafaa El Sadr; Christian Pradier; Signe W Worm
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 2.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

3.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

4.  Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy.

Authors:  K E Poundstone; R E Chaisson; R D Moore
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

5.  The effect of hospital experience on mortality among patients hospitalized with acquired immunodeficiency syndrome in California.

Authors:  W E Cunningham; D M Tisnado; H H Lui; T T Nakazono; D M Carlisle
Journal:  Am J Med       Date:  1999-08       Impact factor: 4.965

6.  Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.

Authors:  Isaline Coquet; Juliette Pavie; Pierre Palmer; François Barbier; Stéphane Legriel; Julien Mayaux; Jean Michel Molina; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care       Date:  2010-06-09       Impact factor: 9.097

7.  Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.

Authors:  Diana C Lemly; Bryan E Shepherd; Todd Hulgan; Peter Rebeiro; Samuel Stinnette; Robert B Blackwell; Sally Bebawy; Asghar Kheshti; Timothy R Sterling; Stephen P Raffanti
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

8.  Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS.

Authors:  Mari M Kitahata; Stephen E Van Rompaey; Peter W Dillingham; Thomas D Koepsell; Richard A Deyo; Wayne Dodge; Edward H Wagner
Journal:  J Gen Intern Med       Date:  2003-02       Impact factor: 5.128

9.  Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy.

Authors:  Krista Powell; J Lucian Davis; Alison M Morris; Amy Chi; Matthew R Bensley; Laurence Huang
Journal:  Chest       Date:  2008-08-21       Impact factor: 9.410

10.  Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions.

Authors:  S Vella; A Chiesi; A Volpi; M Giuliano; M Floridia; L G Dally; N Binkin
Journal:  JAMA       Date:  1994-04-20       Impact factor: 56.272

View more
  22 in total

1.  Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study.

Authors:  Cristiane C Lamas; Lara E Coelho; Beatriz J Grinsztejn; Valdilea G Veloso
Journal:  Infection       Date:  2017-06-28       Impact factor: 3.553

2.  Hospitalization Rates and Outcomes Among Persons Living With Human Immunodeficiency Virus in the Southeastern United States, 1996-2016.

Authors:  Thibaut Davy-Mendez; Sonia Napravnik; David A Wohl; Amy L Durr; Oksana Zakharova; Claire E Farel; Joseph J Eron
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

3.  Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011.

Authors:  Annie Cowell; Sheela V Shenoi; Tassos C Kyriakides; Gerald Friedland; Lydia Aoun Barakat
Journal:  J Hosp Med       Date:  2015-06-30       Impact factor: 2.960

4.  Thirty-day Readmission Rates in an HIV-infected Cohort From Rio de Janeiro, Brazil.

Authors:  Lara E Coelho; Sayonara R Ribeiro; Andre M Japiassu; Ronaldo I Moreira; Priscila C Lara; Valdilea G Veloso; Beatriz Grinsztejn; Paula M Luz
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-01       Impact factor: 3.731

5.  Examining Mortality to Identify Opportunities for Improved Care Among Adults with HIV in a Single Academic Medical Center.

Authors:  Adam M Ressler; Mona Abdo; Samantha MaWhinney; Steven C Johnson; Kristine M Erlandson
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-23       Impact factor: 2.205

6.  A new cytokine release assay: a simple approach to monitor the immune status of HIV-infected patients.

Authors:  I Kaufmann; R Draenert; M Gruber; M Feuerecker; J Roider; A Choukèr
Journal:  Infection       Date:  2013-03-28       Impact factor: 3.553

7.  Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature.

Authors:  C Schwarze-Zander; D Klingmüller; J Klümper; C P Strassburg; J K Rockstroh
Journal:  Infection       Date:  2013-07-20       Impact factor: 3.553

8.  Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection.

Authors:  Edwin Leeansyah; Jenny Svärd; Joana Dias; Marcus Buggert; Jessica Nyström; Máire F Quigley; Markus Moll; Anders Sönnerborg; Piotr Nowak; Johan K Sandberg
Journal:  PLoS Pathog       Date:  2015-08-21       Impact factor: 6.823

9.  Transient Elastography for the Detection of Liver Damage in Patients with HIV.

Authors:  Abdurrahman Sagir; Birgit Glaubach; Kurtulus Sahin; Dirk Graf; Andreas Erhardt; Mark Oette; Dieter Häussinger
Journal:  Infect Dis Ther       Date:  2015-07-05

Review 10.  Epidemiology of severe sepsis.

Authors:  Florian B Mayr; Sachin Yende; Derek C Angus
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.